First human trial launches for experimental prostate cancer treatment
NCT ID NCT07336446
First seen Jan 17, 2026 · Last updated Apr 21, 2026 · Updated 12 times
Summary
This study is testing a new drug called AZD9750 for men with metastatic prostate cancer that has spread. Researchers want to see if the drug is safe, how the body processes it, and if it shows early signs of fighting the cancer. The trial will test AZD9750 alone and combined with another cancer drug in about 300 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Duarte, California, 91010, United States
-
Research Site
Boston, Massachusetts, 02114, United States
-
Research Site
St Louis, Missouri, 63156, United States
-
Research Site
Myrtle Beach, South Carolina, 29572, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Melbourne, 3000, Australia
-
Research Site
Vancouver, British Columbia, V5Z 1H7, Canada
-
Research Site
Chūōku, 104-0045, Japan
-
Research Site
Kashiwa, 227-8577, Japan
Conditions
Explore the condition pages connected to this study.